OALBE0603 Costs and cost-effectiveness of immediate initiation of antiretroviral therapy upon diagnosis of HIV (Rapid Start) in the United StatesOral abstract session with live Q&ACosting, cost effectiveness and affordability
OALBE0604 Feasibility and acceptability of delivering event driven PrEP (9ED-PrEP) to prevent HIV among MSM: a pilot project in Harare, ZimbabweOral abstract session with live Q&AImplementation science and scale up of prevention
OALBE0605 Key population-led same-day antiretroviral therapy initiation hubs in Bangkok, Thailand: an evaluation of HIV cascade outcomes from a hybrid type 3 implementation-effectiveness trialOral abstract session with live Q&AImplementation science and scale up of treatment
OALBX0102 Doravirine/Islatravir (100mg/0.75mg) once daily compared to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as Initial HIV-1 treatment: 48 week results from a double-blind phase 3 trialOral abstract session with live Q&AAntiretroviral therapies and clinical issues in adults
OALBX0103 A social network-based intervention increases HIV self-testing and linkage to health facilities among fishermen in KenyaOral abstract session with live Q&APopulation-specific interventions for HIV prevention
OALBX0104 Sustained aviraemia in the absence of anti-retroviral therapy in male children following in utero vertical HIV transmissionOral abstract session with live Q&AHost immune responses, vaccines and immunotherapies
OALBX0105 Socioeconomic support to improve completion of tuberculosis preventive therapy among adults starting HIV treatment in Tanzania: a quasi-cluster randomized trialOral abstract session with live Q&AIntegration of HIV services with other health and support services
OALBX0202 Positive Predictive Value of HIV Serological Tests in HPTN 084 TrialOral abstract session with live Q&AHIV testing
OALBX0203 Initial PrEP product choice: results from the HPTN 084 open-label extensionOral abstract session with live Q&AHIV prevention research
OALBX0204 Racial disparities in HIV incidence and PrEP non-adherence among gay and other men who have sex with men (MSM) and transgender women (TGW) using oral PrEP in Brazil: ImPrEP StudyOral abstract session with live Q&AHIV prevention research
111 - 120 of 1427 items